RTX Corp: Form 10-Q for the period ended Sep 30, 2013
Filed with the SEC on Oct 25, 2013 and accepted by EDGAR at Oct 25, 2013, 10:59 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-07-01 to 2013-09-30 | $15.46bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months2013-01-01 to 2013-09-30 | $45.87bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2013-07-01 to 2013-09-30 | $8.32bn | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months2013-01-01 to 2013-09-30 | $24.88bn | us-gaap:CostOfGoodsSold |
| Research and development | 3 months2013-07-01 to 2013-09-30 | $630.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2013-01-01 to 2013-09-30 | $1.87bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2013-07-01 to 2013-09-30 | $1.63bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2013-01-01 to 2013-09-30 | $5.00bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2013-07-01 to 2013-09-30 | $2.37bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2013-01-01 to 2013-09-30 | $6.88bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2013-07-01 to 2013-09-30 | $614.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2013-01-01 to 2013-09-30 | $1.68bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-07-01 to 2013-09-30 | $1.43bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2013-01-01 to 2013-09-30 | $4.26bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2013-07-01 to 2013-09-30 | $1.57 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2013-01-01 to 2013-09-30 | $4.66 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2013-07-01 to 2013-09-30 | $1.59 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2013-01-01 to 2013-09-30 | $4.73 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2013-07-01 to 2013-09-30 | 915,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2013-01-01 to 2013-09-30 | 914,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2013-01-01 to 2013-09-30 | $4.89bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months2013-01-01 to 2013-09-30 | $1.05bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2013-01-01 to 2013-09-30 | $1.40bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2013-01-01 to 2013-09-30 | $1.00bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2013-09-30 | $29.35bn | us-gaap:AssetsCurrent |
| Total assets | At period end2013-09-30 | $90.33bn | us-gaap:Assets |
| Current liabilities | At period end2013-09-30 | $23.52bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-09-30 | $60.28bn | us-gaap:Liabilities |
| Long-term debt | At period end2013-09-30 | $20.89bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2013-09-30 | $303.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2013-09-30 | $28.58bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2013-09-30 | 917,581,965 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000101829-13-000045. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.